Immunoglobulins in the larynx in systemic lupus erythematosus.
D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis; D001485:Basement Membrane / Q000276:immunology; D003165:Complement System Proteins / Q000032:analysis; D003520:Cyclophosphamide / Q000627:therapeutic use; D004576:Electromyography; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis*; D007830:Larynx / Q000276:immunology*; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D009504:Neutrophils; D010587:Phagocytosis; D011241:Prednisone / Q000627:therapeutic use; D012131:Respiratory Insufficiency / Q000209:etiology
D000974:Antibodies, Antinuclear; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D003520:Cyclophosphamide; D003165:Complement System Proteins; D011241:Prednisone